Guevara TA

Language: Spanish
References: 18
Page: 275-283
PDF size: 190.63 Kb.

ABSTRACT

Objective: To analyze and compare the relationship between LYVE-1 and the inflammatory and regenerative biomarkers TFF-1, creatinine, REG-1A, REG-1B, and CA19-9 in healthy individuals and patients with chronic pancreatitis.
Materials and Methods: Analytical, cross-sectional study using secondary data from an open-access article reviewing the role of urinary biomarkers in the early detection of pancreatic cancer. Correlations between LYVE-1 and other biomarkers were analyzed using Spearman's correlation coefficient and multivariate linear regression models. The results were stratified by study group.
Results: A total of 119 healthy subjects and 183 patients with pancreatitis were analyzed. In the former, the correlations of LYVE-1 were: REG-1B (rho = 0.544; p ‹ 0.001), REG-1A (rho = 0.553; p ‹ 0.001), TFF-1 (rho = 0.464, p ‹ 0.001), creatinine (rho = 0.282, p = 0.002), CA19-9 (rho = 0.343; p = 0.006). In patients with pancreatitis: TFF-1 (rho = 0.725; p ‹ 0.001), creatinine (r = 0.659; p ‹ 0.001), REG-1B (rho = 0.459; p ‹ 0.001). REG-1A (rho = 0.492; p ‹ 0.001) and plasma CA19-9 (rho = 0.410; p ‹ 0.001). In chronic pancreatitis, the regression model showed that REG-1B (B = 0.012; p = 0.003) was the only factor associated with LYVE-1, with an R² of 0.386. The model was statistically significant (F = 4.778; p = 0.002).
Conclusions: LYVE-1 shows distinct patterns of association with biomarkers of regeneration, inflammation, and organ dysfunction in healthy individuals and patients with pancreatitis. Its dynamic role, adapted to homeostatic or inflammatory contexts, positions it as an integral biomarker for the assessment and monitoring of pancreatitis and its systemic complications.

REFERENCES

1. Kichler A, Jang S. Chronic pancreatitis: Epidemiology, diagnosis,and management updates. Drugs 2020; 80 (12):1155-68. http://dx.doi.org/10.1007/s40265-020-01360-6

2. Hart PA, Conwell DL. Chronic pancreatitis: Managing adifficult disease. Am J Gastroenterol 2020; 115 (1): 49-55.http://dx.doi.org/10.14309/ajg.0000000000000421

3. Yu J, Liu C, Zhang J, Wang X, et al. Global, regional, andnational burden of pancreatitis in older adults, 1990–2019:A systematic analysis for the global burden of disease study2019. Prev Med Rep 2024; 41 (102722): 102722. http://dx.doi.org/10.1016/j.pmedr.2024.102722

4. Li T, Qin C, Zhao B, Li Z, et al. Global and regional burdenof pancreatitis: epidemiological trends, risk factors, andprojections to 2050 from the global burden of diseasestudy 2021. BMC Gastroenterol 2024; 24 (1). http://dx.doi.org/10.1186/s12876-024-03481-8

5. Hu Z, Zhao X, Wu Z, Qu B, et al. Lymphatic vessel: Origin,heterogeneity, biological functions and therapeutic targets.Signal Transduct Target Ther 2024; 9 (1): 1-37. https://www.nature.com/articles/s41392-023-01723-x

6. Banerji S, Lawrance W, Metcalfe C, Briggs DC, et al. Homodimerizationof the lymph vessel endothelial receptor LYVE-1through a redox-labile disulfide is critical for hyaluronanbinding in lymphatic endothelium. J Biol Chem 2016; 291(48): 25004-18. http://dx.doi.org/10.1074/jbc.m116.736926

7. Stritt S, Koltowska K, Mäkinen T. Homeostatic maintenanceof the lymphatic vasculature. Trends Mol Med .2021;27(10):955–70. http://dx.doi.org/10.1016/j.molmed.2021.07.003

8. Dinesh MG, Bacanin N, Askar SS, Abouhawwash M.Diagnostic ability of deep learning in detection of pancreatictumour. Sci Rep . 2023 [citado 15 de diciembrede 2024];13(1):1–19. https://www.nature.com/articles/s41598-023-36886-8

9. Aihara E, Engevik KA, Montrose MH. Trefoil factor peptidesand gastrointestinal function. Annu Rev Physiol .2017;79(1):357–80. http://dx.doi.org/10.1146/annurevphysiol-021115-105447

10. Chen W, Imasaka M, Lee M, Fukui H, Nishiura H, OhmurayaM. Reg family proteins contribute to inflammationand pancreatic stellate cells activation in chronicpancreatitis. Sci Rep . 2023 [citado 13 de diciembre de2024];13(1):1–10. https://www.nature.com/articles/s41598-023-39178-3

11. Hiramoto JS, Katz R, Peralta CA, Ix JH, Fried L, Cushman M,et al. Inflammation and coagulation markers and kidneyfunction decline: The multi-ethnic study of atherosclerosis(MESA). Am J Kidney Dis . 2012;60(2):225–32. http://dx.doi.org/10.1053/j.ajkd.2012.02.335

12. Law J, Trieu H, Kaleka G, Turkiewicz J, Palmer S, Lee JM,et al. Clinical features and outcomes of patients withpancreaticobiliary malignancies in Los Angeles county andtheir association with CA 19-9 levels. Cancers (Basel) . 2023[citado 15 de diciembre de 2024];15(6):1723. https://www.mdpi.com/2072-6694/15/6/1723

13. Glaubitz J, Asgarbeik S, Lange R, Mazloum H, Elsheikh H,Weiss FU, et al. Immune response mechanisms in acute andchronic pancreatitis: strategies for therapeutic intervention.Front Immunol . 2023;14. http://dx.doi.org/10.3389/fimmu.2023.1279539

14. Debernardi S, O’Brien H, Algahmdi AS, Malats N, StewartGD, Plješa-Ercegovac M, et al. A combination of urinarybiomarker panel and PancRISK score for earlier detectionof pancreatic cancer: A case–control study. PLoS Med .2020;17(12):e1003489. http://dx.doi.org/10.1371/journal.pmed.1003489

15. Baker ML, Cantley LG. The lymphatic system in kidneydisease. Kidney360 . 2023;4(6):e841–50. http://dx.doi.org/10.34067/kid.0000000000000120

16. Nassar TI, Qunibi WY. AKI associated with acute pancreatitis.Clin J Am Soc Nephrol . 2019;14(7):1106–15. http://dx.doi.org/10.2215/cjn.13191118

17. Falvo DJ, Grimont A, Zumbo P, Fall WB, Yang JL, OsterhoudtA, et al. A reversible epigenetic memory of inflammatoryinjury controls lineage plasticity and tumor initiation inthe mouse pancreas. Dev Cell . 2023;58(24):2959-2973.e7.http://dx.doi.org/10.1016/j.devcel.2023.11.008

18. Buron N, Guery L, Creuzot-Garcher C, Lafontaine P-O, et al.Trefoil factor TFF-1-induced protection of conjunctival cellsfrom apoptosis at premitochondrial and postmitochondriallevels. Invest Ophthalmol Vis Sci 2008; 49 (9): 3790. http://dx.doi.org/10.1167/iovs.07-1270